Skip to main content

Table 2 Rate and duration of post-baseline psychiatric hospitalizationsa

From: Baseline characteristics and hospitalizations in patients with schizophrenia receiving olanzapine long-acting injection: an interim analysis from a non-interventional, prospective observational safety study

Baseline Hospitalizationb

Characteristic

Patients with ≥1 Olanzapine LAI Injection

Patients with Opportunity for >6-months Follow-up

No

N

529

288

Patients with ≥1 post-baseline hospitalization, n (%)

43 (8.1)

24 (8.3)

Days of hospitalization, mean (SD)

2.0 (12.0)

2.3 (14.3)

Days of hospitalizations among patients with a hospitalization, mean (SD)

24.9 (35.0)

27.0 (43.1)

Yes

N

56

29

Patients with ≥1 post-baseline hospitalization, n (%)

6 (10.7)

5 (17.2)

Days of hospitalization, mean (SD)

3.6 (20.5)

6.8 (28.3)

Days of hospitalizations among patients with a hospitalization, mean (SD)

33.3 (58.5)

39.4 (63.3)

  1. Abbreviations: LAI long-acting injection, N/n number of patients, SD standard deviation
  2. aAnalysis included only patients who started treatment with olanzapine LAI at time of study entry
  3. bDefined as hospitalization upon initiation of olanzapine LAI treatment